Medblaze
AMR numbers that matter, the new Global Action Plan 2026–2036, India’s NAP-AMR 2.0, and what your hospital can do this week.
A 62-year-old is two days into a post-operative ICU stay when the blood culture comes back: carbapenem-resistant Klebsiella. The antibiotic that should have worked does not. The options left are older, more toxic and more expensive, and the odds have shifted.
This is no longer a rare case report. It is a Tuesday in many Indian tertiary hospitals. World AMR Awareness Week 2026 runs from 18 to 24 November under the theme One Health, one action: Prevent AMR now. Resistance does not stay in one ward, one farm or one river, so prevention cannot either. Here is what the numbers say, what the new global and Indian plans demand, and what your hospital can do this week.
What is antimicrobial resistance, and why One Health?
Antimicrobial resistance happens when bacteria, viruses, fungi and parasites stop responding to the drugs designed to kill them. Antibiotics, antifungals, antivirals and antiparasitics lose their effect, and routine infections become hard or impossible to treat.
The main drivers are familiar to anyone who has sat on a hospital infection control committee:
- Antibiotics prescribed without a clear indication, at the wrong dose, or for too long
- Over-the-counter sales and self-medication
- Weak infection prevention and control, which lets resistant organisms spread between patients
- Antibiotic use in livestock, poultry and aquaculture
- Effluent from hospitals, farms and pharmaceutical plants reaching water and soil
That last pair is why the 2026 theme leans on One Health. The health of people, animals, plants and the environment is linked, and action in one sector shapes risk in the others.
A colistin-resistance gene that emerges on a poultry farm does not need a referral to reach your ICU.
The global AMR picture in five numbers
AMR already kills more than a million people a year, and the trend line points up.
Global burden
Bacterial AMR, measured and projected
Sources: GRAM for the death figures and projection; WHO GLASS for the resistance shares.
Two patterns matter for hospital leaders. First, the burden is shifting to older adults: AMR deaths in people over 70 rose by more than 80% between 1990 and 2021, while deaths in under-fives fell by more than half. Your ageing, multimorbid inpatients are the frontline.
Second, resistance is climbing in the drugs we hold in reserve. Between 2018 and 2023, resistance rose in more than 40% of the pathogen and antibiotic pairs WHO tracks, and carbapenem resistance, once rare, is becoming common. Without action, AMR could cost the global economy over US$3.4 trillion a year.
Antimicrobial resistance in India: where the data points
India carries one of the heaviest AMR burdens in the world, and its most dangerous resistant infections are concentrated in hospitals.
- Deaths. IHME estimates put India’s 2019 toll at about 297,000 deaths directly attributable to AMR and over 1 million associated with it. GRAM forecasts expect South Asia, including India, to be hit hardest through 2050.
- Resistance trends. The ICMR AMR Surveillance Network studied 99,027 culture-positive isolates in 2024 and recorded year-on-year rises in resistance to agents such as cefotaxime, ceftazidime and amikacin. Across 21 ICMR centres, imipenem and meropenem resistance in Klebsiella, E. coli and Acinetobacter bloodstream infections rose significantly every month from 2017 to 2022.
- Where it starts. In those bloodstream infections, carbapenem resistance appeared in hospital-acquired cases before community-acquired ones. Hospitals are not just treating resistance; they are incubating it.
- What it costs patients. An ICMR study of 20 tertiary hospitals between 2022 and 2025 found carbapenem-resistant Gram-negative infections carried higher mortality, longer stays and higher costs than susceptible ones. Bloodstream infection mortality reached 46% to 51% for carbapenem-resistant Acinetobacter, Pseudomonas and Klebsiella, and over 85% of these infections were healthcare-associated.
For a quality manager, that last figure is the headline. Most of India’s deadliest resistant infections are, in principle, preventable harm.
The Global Action Plan on AMR 2026 to 2036
On 23 May 2026, the 79th World Health Assembly adopted the updated Global Action Plan on AMR, the first full overhaul since 2015. WOAH’s 183 member countries adopted it two days earlier, and FAO and UNEP are completing their own approvals. It is the global framework for AMR action through 2036, built to help countries develop and finance multisectoral national action plans.
What changed from 2015
The 2015 plan put AMR on the agenda but set no time-bound numeric targets. A decade on, only 68% of 178 national action plans were being implemented and just 11% were domestically funded. The new plan adds a sixth objective on governance, financing and accountability to close that gap.
The six strategic objectives
- Strengthen awareness and promote social and behavioural change
- Strengthen surveillance systems and laboratory networks
- Intensify infection prevention and control
- Ensure equitable access, appropriate use and safe disposal of antimicrobials and diagnostics
- Accelerate AMR research and innovation
- Strengthen multisectoral governance, sustainable financing and accountability
The 2030 targets hospitals will be measured against
The plan carries forward the commitments of the 2024 UN Political Declaration on AMR.
2030 targets
What the next four years are supposed to deliver
The Quadripartite is now drafting cross-sectoral operational guidance and a monitoring and evaluation framework. The next decade will be judged on data, not declarations.
How India is acting on AMR
India’s response has moved from awareness campaigns to a costed, ministry-by-ministry plan. Delivery now sits with states and hospitals.
NAP-AMR 2.0, covering 2025 to 2029
India launched its second National Action Plan on AMR on 18 November 2025, the first day of last year’s awareness week. It follows NAP-AMR 1.0 and sets out action plans for each stakeholder ministry with budgets and coordination mechanisms. It also widens surveillance to resistance and antibiotic residues in wastewater from hospitals, farms and pharmaceutical units.
The supporting architecture
India’s AMR machinery
Five pieces already in place
- ICMR AMRSN. Hospital-based AMR surveillance network, running since 2013.
- NCDC NARS-Net. National surveillance of nine priority pathogens under the AMR containment programme.
- Red Line campaign. Tells the public not to use red-line-marked medicines, including antibiotics, without a prescription.
- Colistin ban, 2019. Prohibited colistin for food-producing animals, poultry, aquaculture and feed supplements.
- WHO GLASS. India has reported national AMR data to the global system since 2017.
Kerala shows what state ownership looks like
Kerala adopted India’s first state AMR action plan in 2018. Strict enforcement of prescription-only antibiotic sales cut state antibiotic consumption by an estimated 20% to 30%, and the state is making every hospital “antibiotic smart”. Its surveillance network draws data from 59 tertiary hospitals and is the only one in India covering primary and secondary care.
The lesson for other states, and for private hospital groups: national plans only bite when someone local measures, enforces and reports.
One action per hospital this week
The global targets translate into a short, measurable hospital agenda. Pick the gap you can close first.
This month
Six actions, each with a number to track
Publish your antibiogram
Share a unit-wise cumulative antibiogram with prescribers. Track the share of empirical regimens aligned to it.
Audit bundles weekly
Check CLABSI, CAUTI, VAP and SSI bundle compliance weekly, not quarterly. Track HAI rate per 1,000 device or patient days.
Watch the Access share
Track Access, Watch and Reserve use, and require approval for Reserve agents. Target at least 70% of use from the Access group.
Add a 72-hour time-out
Build a 48 to 72-hour antibiotic review into ward rounds. Track the share of courses actually reviewed at 72 hours.
Train and tell
Train every prescriber and nurse on your antibiotic policy, and tell patients about the Red Line. Track staff trained and run a patient awareness audit.
Report to the board
Have the stewardship committee report AMR metrics to the board quarterly. The measure is simple: does a board-reviewed AMR dashboard exist?
NABH already expects much of this. Its infection control standards cover surveillance, antibiotic policy and stewardship. In 2026, regulators and payers will increasingly ask to see the trend, not the policy document.
Why AMR prevention needs a digital quality system
Most Indian hospitals already collect the raw material for AMR control: culture reports, antibiotic orders, HAI cases, bundle audits. The problem is that it lives in the laboratory system, the pharmacy, a spreadsheet and the infection control nurse’s register, and rarely meets in time to change a prescription.
A digital quality management system fixes the plumbing. It joins surveillance, stewardship, audits and training in one place, so the stewardship committee sees a single trend line instead of four reports. Medblaze Infini does this within its Infection Surveillance module:
- Structured infection case capture with standard definitions for CLABSI, CAUTI, VAP and SSI, and a verify-before-count workflow
- Antibiogram and stewardship analytics that turn culture data into unit-level resistance patterns prescribers can use
- Live dashboards for HAI rates and AMR indicators across wards and facilities
- Audits and learning in one platform: bundle audits, corrective actions through incident management and RCA, and stewardship training
- Accreditation readiness, with NABH-aligned records assessors can trace from detection to closure
The point is getting the 72-hour antibiotic review, the antibiogram and the board dashboard to run on the same data, every week.
Key takeaways
- World AMR Awareness Week 2026, from 18 to 24 November, asks every sector to take one concrete action under a One Health approach.
- Bacterial AMR directly caused 1.14 million deaths in 2021, and over 39 million are projected between 2025 and 2050.
- In WHO’s South-East Asia region, 1 in 3 common bacterial infections is now resistant.
- The Global Action Plan 2026 to 2036 adds accountability and financing, targeting a 10% cut in AMR deaths and at least 70% Access antibiotic use by 2030.
- India’s NAP-AMR 2.0 assigns budgets and roles by ministry, and Kerala shows enforcement works.
- Hospitals hold the biggest lever: most deadly carbapenem-resistant bloodstream infections in Indian tertiary care are healthcare-associated.
Frequently asked questions
When is World AMR Awareness Week 2026 and what is the theme?
World AMR Awareness Week runs every year from 18 to 24 November. The 2026 theme is “One Health, one action: Prevent AMR now”. It calls on governments, health workers, veterinarians, farmers, environmental experts and communities to act together, since resistance spreads across human, animal, plant and environmental health.
What is the Global Action Plan on AMR 2026 to 2036?
It is the updated global framework for AMR, adopted by the World Health Assembly on 23 May 2026 after WOAH adopted it on 21 May. It replaces the 2015 plan, has six strategic objectives, and carries forward 2030 targets such as a 10% reduction in deaths associated with bacterial AMR.
What is NAP-AMR 2.0 in India?
NAP-AMR 2.0 is India’s second National Action Plan on Antimicrobial Resistance, covering 2025 to 2029 and launched on 18 November 2025. It follows a One Health approach, sets out ministry-specific plans with budgets, and expands surveillance to wastewater from hospitals, farms and pharmaceutical plants.
How bad is antimicrobial resistance in India?
IHME estimates about 297,000 deaths directly attributable to AMR in India in 2019 and over a million associated deaths. ICMR surveillance shows rising resistance to carbapenems and other key antibiotics in Klebsiella, E. coli and Acinetobacter, with the highest resistance in ICUs.
What can a hospital do to prevent AMR?
Start with a working antimicrobial stewardship programme: a local antibiogram, approval rules for Reserve antibiotics, 72-hour antibiotic reviews and tracking of Access-group use. Pair it with strict infection prevention bundles, staff training and a board-level dashboard so progress is measured and reported.
How does software help antimicrobial stewardship?
A digital quality management system links culture results, antibiotic use, infection cases and audits in one place. That makes it possible to build antibiograms, spot outbreaks and track stewardship metrics weekly rather than after a quarterly manual compilation.
Conclusion
The 62-year-old in the ICU did not acquire carbapenem resistance by bad luck. It reached her through a chain of prescriptions, hands, devices and supply lines that each of us touches. The new global plan and India’s NAP-AMR 2.0 set the direction for the decade; hospitals decide whether the numbers move.
This World AMR Awareness Week, take one action and measure it. Antibiotics are a shared resource, and preventing AMR is now part of every hospital’s job.
References
- Quadripartite (WHO, FAO, UNEP, WOAH). World AMR Awareness Week 2026; WOAH, WAAW 2026.
- GRAM Project, The Lancet, September 2024, via The Pharmaceutical Journal and Cosmos.
- WHO. Global antibiotic resistance surveillance report 2025.
- RSTMH. UN General Assembly target to reduce AMR deaths by 10% by 2030.
- WHO. World Health Assembly adopts the updated Global Action Plan on AMR 2026 to 2036.
- WOAH. WOAH members adopt the updated Global Action Plan on AMR.
- Health and Global Policy Institute. AMR Policy Update #6 and #7.
- BW Healthcare World. IMA national alliance on AMR, citing IHME 2019 India estimates.
- ICMR. AMRSN Annual Report 2024.
- ICMR AMRSN. Mortality and cost of carbapenem-resistant Gram-negative infections, 2022 to 2025.
- Kaur J, Singh H, et al. AMR trends in bloodstream infections in India, 2017 to 2022. Lancet Regional Health South-East Asia, 2024.
- Down To Earth. India releases NAP-AMR 2.0.
- Medical Dialogues. Red Line campaign and NARS-Net.
- The South First. Kerala crackdown on antibiotic misuse.
- ARIC. Key steps in AMR regulation in India.
- Modern Ghana. When the last-resort antibiotic fails.
- Vision IAS. NAP-AMR 2.0: India’s blueprint.
- EnsureIAS. AMR: global trends, India and Kerala.